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Introduction
Gastrointestinal tract (GI) cancers including 
esophageal, stomach and colorectal cancer are considered 
to be the three most common cancers in Asia and Iran as 
well (Ghadimi et al., 2012; Pourhoseingholi et al., 2015). 
According to the International Agency for Research on 
Cancer (IARC), esophageal cancer (EC) is responsible for 
approximately 386,000 deaths per year and is considered 
to be the sixth most common cause of cancer worldwide. , 
Based on the analysis of a series of cases referred to clinics 
and the universities in Shiraz and Tehran, Northeastern of 
Iran has one of the highest rates of EC. These analyses 
revealed that approximately 3-4% of all registered cancers 
were esophageal cancer (Sadjadi et al., 2005). 
Gastric cancer (GC) is one of the most common 
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cancers of the upper gastrointestinal tract (GI). Previous 
studies have shown that GC remains the seventh most 
common cancer in the United States and it is still the most 
common cancer in northern regions of Iran (Malekzadeh et 
al., 2009; Hu et al., 2012). Usually, patients are referred to 
hospitals in their advanced stages of the disease. Although 
the incidence of GC has decreased in recent years, 
approximately 990,000 people are diagnosed with GC 
each year worldwide and about 738,000 of them die due 
to GC (Karimi et al., 2014). According to the reports from 
the Iranian Ministry of Health and recent related studies, 
GI cancers such as EC and GC are the most common 
cancers in the East-Azarbaijan province (Naghavi, 2001; 
Somi et al., 2014; Darabi et al., 2016) but few studies have 
been conducted on the occurrence of GI cancers, their 
survival rates, and their related risk factors. Also, since 
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the incidence of GI cancers in East-Azarbayjan Province 
is significantly high (Somi et al., 2014), identifying the 
potential risk factor of these fatal diseases with appropriate 
tools is necessary.
Due to the increasing use of survival analysis including 
semi-parametric and parametric multivariable survival 
models in medical studies, especially in cancer research, 
the need for efficient models with more flexibility is 
necessary. Despite the popularity of the semi-parametric 
models like the Cox Proportional Hazard model, 
parametric approaches can be better alternatives in some 
circumstances (Ghadimi et al., 2011). Although one of 
the most critical assumptions of the Cox Proportional 
Hazard Model is holding proportionality hazards (PH) 
assumption, in several clinical setting this underlying 
assumption does not hold. In such situations, accelerated 
failure time parametric survival techniques can be used 
to model risk factors for rare diseases (Kleinbaum and 
Klein, 2012; Cox, 2018). 
This study aimed to assess the potential risk factors of 
patients with EC and GC in the East Azarbaijan province 
of Iran using the best parametric survival model. Also, by 
using proper statistical methods, the shared risk factors 
between the two cancers were then determined for the first 
time in a sample of Iranian patients.
Materials and Methods
This retrospective cohort study utilized information on 
patients with gastrointestinal cancers that were registered 
during the years 2009-2010 in Iran’s National Cancer 
Control Registration Program. In this national program, 
all pathology centers, health centers, and hospitals in 
provinces are obligated to report their data to the Cancer 
Office of Disease Control and Prevention. The data sets 
of this study were collected from 127 cases of patient 
with EC and 184 cases of patient with GC who lived 
in the cities of East-Azarbaijan Province. The patients 
that were referred to health centers and hospitals in this 
province were followed up for five years until 2015 and 
their information was extracted from their records. The 
patients were contacted via phone to gather information 
about their health and survival. The beginning of the study 
was assumed as the date of the pathologic diagnosis of 
cancer. The study outcome was considered death due to 
EC or GC cancer. Survival time was calculated using the 
difference between the dates of death and the first report 
of their cancer pathology. Patients who survived by the 
end of the study were considered as right censored.
The Two types of cancer sites included in this study 
were defined according to the International Classification 
of Diseases, 10th revision. 184 GC patients were defined 
by code C16 and 127 EC patients by code C15. In order 
to assess the potential risk factors of EC and GC, patients 
with prior cancers were excluded from this study. Also, 
there is no loss to follow-up in this study. In addition, the 
current study data is extracted from a MSc thesis which 
was checked and approved by the Ethics Committee of 
the TUMS (IR.TUMS.DDRI.REC.1396.4148).
The current study included three types of information: 
demographic, biological and socioeconomic data. 
The demographic variables were the age at the time 
of diagnosis, gender, educational status, marital 
status, and job status. The biological variables were 
non-communicable disease (NCD) affected status, 
Esophagectomy surgery, chemotherapy, and radiotherapy. 
In addition, socioeconomic status (SES) obtained based 
on a checklist of wealth and social position characteristics 
such as household fuel consumption, residential facilities, 
personal family facilities, and household appliances 
used by the family, total monthly household income, 
education status, and job status. Principle component 
factor analysis was applied to obtain the socioeconomic 
status (EC: KMO=0.722, Bartlett’s Sphericity test 
p-value<0.001; GC: KMO=0.788, Bartlett’s Sphericity 
test p-value<0.001). The extracted score was categorized 
by the median to low and high level. 
Statistical Analysis
Descriptive characteristics of the patients are shown as 
mean (± standard deviation) and frequency (percentage) 
for continuous and categorical variables respectively. 
Log-rank test was performed to assess the difference in 
the distribution among the levels of variables. The Cox 
Proportional Hazard model was performed for both EC 
and GC cancers, and also PH assumption was checked to 
take advantage of using this model in the current study. 
Akaike Information Criteria (AIC) was utilized to compare 
the performance of parametric survival models (EC AICs’ 
models: Log-logistic=337.94, Exponential= 343.90, 
Weibull=343.82; GC AICs’ models: Log-logistic=577.77, 
Exponential= 621.44, Weibull=601.01). 
The univariate parametric model was used to assess the 
risk factors in EC and GC patients. Since the log-logistic 
model was recognized as the best model among the others, 
all the variables were entered in the multivariable Log-
logistic model to find the adjusted effects of the factors 
on patients’ survival. Chemotherapy was removed from 
the multivariable model due to its high collinearity with 
the other predictors. The results were presented as Odds 
Ratio (OR) in Log-logistic models. Comparison of the 
estimated coefficients (beta) that resulted from the two 
parametric models could indicate the difference of the 
effect of factors on the survival of the two cancers. So, 
we fit another multivariable log-logistic model using a 
merge file of both EC and GC datasets. The type of cancer 
and its interactions with each of the factors is also added 
into this new model. These newly modified interactions 
assess the magnitude of the effect of various factors 
on the cancers. The non-significant difference between 
interactions estimation indicates comparable magnitude of 
the factor on the survival of the two cancers. All analysis 
performed using STATA (version 12) and the p-value<0.05 
was considered statistically significant. 
Results
The following results were found from 184 GC and 
127 EC patients. The mean (± standard deviation) age of 
the 184 GC patients was 66.5 (± 11.5) years. The survival 
time ranged from 0.07 to 70.33 month and the mean 
and median survival time was 16.8 (95% CI: 13.6-19.9) 
Asian Pacific Journal of Cancer Prevention, Vol 20 445
DOI:10.31557/APJCP.2019.20.2.443
 Gastric and Esophageal Cancers
(p-value=0.035) and GC (p-value= 0.044), parametric 
models can be selected as useful alternatives in this study. 
According to the results of AICs from multivariable 
parametric models, the Log-Logistic model had the best 
fitting distribution compared to other parametric models. 
The patients’ characteristics, log-rank test and 
univariate log-logistic model for EC and GC are shown 
in Tables 1 and 2 respectively. According to the log-rank 
results, EC survival time was significantly longer among 
females, unemployed cases, those who had Esophagectomy 
surgery, and patients with high socioeconomic status. 
Gastrointestinal cancers survival-time was influenced by 
Esophagectomy surgery and chemotherapy. Accordingly, 
the results of the univariate log-logistic models showed 
that survival in patients with EC is affected by being male 
(OR=0.45; 95% CI: 0.28-0.73), unemployed(OR=1.81; 
and 8.33 (95% CI: 5.9-10.6) months respectively. One, 
three and five-year survival probabilities in EC and GC 
patients were 40.16%, 11.18%, and 11.02% for EC and 
34.8%, 13% and 11.4% for GC, respectively. A total of 
163 (86.6%) individuals experienced death due to GC 
by the end of the study. Moreover, the mean (± standard 
deviation) age of the 127 patients with esophageal cancer 
was 66.92 (± 11.95) years. The survival time ranged from 
0.10 to 69.03 months and the mean and median survival 
time was 16.99 (95% CI: 13.46-20.52) and 10.06 (95% CI: 
6.49-13.63) months respectively. A total of 113 patients 
(89%) experienced death due to esophageal cancer by the 
end of the study. The Kaplan-Meier survival estimate of 
patients with Esophageal and Gastric Cancers are showed 
in Figure 1 since PH assumption in the Cox regression 
model did not hold in the dataset of patients with EC 
Variable n (%) Death Log-Rank Test Univariate log-logistic model
113 (89%) Mean Survival Time SE* p-value OR** 95% CI***
Age at time of diagnosis 0.384
     ≥50 113 (89) 101 (89.4) 16.52 1.89 0.64 0.30-1.34
     <50 14 (11) 12 (85.7) 19.71 5.02
Gender <0.001
     Male 70 (55.1) 68 (97.1) 10.4 1.29 0.45 0.28-0.73
     Female 57 (44.9) 45 (78.9) 24.45 3.27
Education 0.989
     Illiterate 98 (77.2) 87 (88.8) 17.14 2.08 1.16 0.66-2.04
     Literate 29 (22.8) 26 (89.7) 16.21 3.43
Marital Status 0.524
     Married 86 (67.7) 35 (85.4) 16.96 1.98 1.51 0.89-2.56
     Unmarried 41 (32.3) 78 (90.7) 16.56 3.55
Job Status 0.004
     Unemployed 79 (62.2) 67 (84.8) 20.61 2.52 1.81 1.12-2.94
     Employed 48 (37.8) 46 (95.8) 10.7 1.87
Smoking Habit 0.554
     Yes 42 (33.1) 40 (95.2) 14.39 2.21 0.93 0.56-1.54
     No 85 (66.9) 73 (85.9) 18.07 2.4
NCD affected Status 0.503
     No 103 (81.1) 93 (90.3) 16.3 1.92 0.9 0.47-1.70
     Yes 24 (18.9) 20 (83.3) 18.51 4.15
Esophagectomy surgery <0.001
     Yes 72 (56.7) 59 (81.9) 22.48 2.8 2.08 1.30-3.32
     No 55 (43.3) 54 (98.2) 9.49 1.28
Chemotherapy 0.528
     Yes 55 (43.3) 51 (92.7) 16.8 2.1 1.01 0.99-1.03
     No 72 (56.7) 62 (86.1) 16.52 2.62
Radiotherapy 0.263
     Yes 43 (33.9) 39 (90.7) 18.08 2.6 1.48 0.92-2.41
     No 84 (66.1) 74 (88.1) 16.22 2.31
SES 0.008
     High level 66 (52) 62 (93.9) 21.57 2.9 1.82 1.12-2.95
     Low level 61 (48) 51 (83.6) 12.55 1.97
Table 1. The Esophageal Cancer Patients’ Characteristics and the Results of the Log-Rank Test
*SE, Standard Error;**OR, Odds Ratio; 95%CI, 95% Confidence Interval
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Variable n (%) Death Log-Rank Test Univariate log-logistic model
113 (89%) Mean Survival Time SE* p-value OR** 95% CI**
Age at time of diagnosis 0.275
     ≥50 166 (90.2) 147 (88.6) 15.7 1.65 0.58 0.27-1.24
     <50 18 ( 9.8) 16 (88.9) 20.78 4.78
Gender 0.303
     Male 124 (67.4) 113 (91.1) 14.8 1.75 0.88 0.55-1.42
     Female 60 (32.6) 50 (83.3) 17.68 2.76
Education 0.334
     Illiterate 112 (60.9) 100 (89.3) 15.13 1.96 0.78 0.49-1.22
     Literate 72 (39.1) 63 (87.5) 17.86 2.58
Marital Status 0.208
     Married 149 (81) 131 (87.9) 16.96 1.77 1.65 0.93-2.90
     Unmarried 35 (19) 32 (91.4) 11.72 2.64
Job Status 0.517
     Unemployed 116 (63) 100 (86.2) 17.17 2.11 1.11 0.70-1.74
     Employed 68 (37) 63 (92.6) 14.38 2.16
Smoking Habit 0.714
     Yes 62 (33.7) 56 (90.3) 14.81 2.44 0.98 0.61-1.55
     No 122 (66.3) 107 (87.7) 16.44 1.97
NCD affected Status 0.183
     No 151 (82.1) 136 (90.1) 15.14 1.65 0.7 0.40-1.27
     Yes 33 (17.9) 27 (81.8) 19.59 3.78
Esophagectomy surgery 0.001
     Yes 107 (58.2) 89 (83.2) 20.34 2.34 1.92 1.24-2.97
     No 77 (41.8) 74 (96.1) 10.5 1.66
Chemotherapy 0.027
    Yes 78 (42.4) 69 (88.5) 19.57 2.43 1.85 1.21-2.86
     No 106 (57.6) 94 (88.7) 16.8 2.62
Radiotherapy 0.16
     Yes 26 (14.1) 23 (88.5) 19.18 3.49 1.98 0.89-3.58
     No 158 (85.9) 140 (88.6) 15.57 1.7
SES 0.126
     High level 92 (50) 78 (84.4) 18.67 2.44 1.36 0.88-2.10
     Low level 92 (50) 85 (92.4) 17.74 1.93
Table 2. The Gastric Cancer Patients’ Characteristics and the Results of the Log-Rank Test 
Variable Esophageal Cancer Gastric cancer p-value***
OR* 95% CI** OR 95% CI
Age at time of diagnosis (≥50) 0.9 0.43 - 1.85 0.83 0.37 - 1.88 0.135
Gender (Male) 0.33 0.16 - 0.66 0.82 0.46 - 1.47 <0.001
Education (Illiterate) 1.04 0.61 - 2.43 0.95 0.58 - 1.55 0.009
Marital status (Married) 2.25 1.33 - 3.81 1.48 0.80 - 2.73 <0.001
Job Status (Unemployed) 1.03 0.55 - 1.93 1.05 0.62 - 1.77 0.543
Smoke (Yes) 0.8 0.49 - 1.28 0.93 0.58 - 1.47 <0.001
NCD affected (No) 0.88 0.50 - 1.55 0.65 0.37 - 1.15 <0.001
Esophagectomy surgery (Yes) 1.62 1.04 - 2.55 1.6 1.02 - 2.53 0.835
Radiotherapy (Yes) 1.49 0.94 - 2.36 1.6 0.86 - 2.95 0.047
SES (High Level) 1.35 0.87 - 2.09 1.13 0.71 - 1.78 <0.001
*OR, Odds Ratio; **95% CI, 95% Confidence Interval;*** P-value, Based on analysis of the interaction between type of cancer and each risk 
factor, in a new model.
Table 3. Multivariable Log-Logistic Model in Patients with Esophageal and Gastric Cancers
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95% CI: 1.12-2.94), having Esophagectomy surgery 
(OR=2.08; 95% CI: 1.30- 3.32) or radiotherapy (OR=1.69; 
95% CI: 1.04- 2.75) and high-level SES (OR=1.82; 95% 
CI: 1.12-2.95). Additionally, the odds of survival in 
patients with GC was affected by having Esophagectomy 
surgery (OR=1.92; 95% CI: 1.24-2.97) and chemotherapy 
(OR=1.85; 95% CI: 1.21-2.86).
The results of multivariable Log- logistic model in 
patients with EC and GC are shown in Table 3. Based 
on the multivariable 95% CI for the odds ratios, married 
EC patients were 2.25 (95% CI: 1.33 - 3.81) times more 
likely to survive than unmarried patients. Patients who 
had Esophagectomy surgery had a 62% increase of odds 
of survival (OR: 1.62, 95% CI: 1.04 – 2.55). However, 
survival after diagnosis of GC was only affected by 
Esophagectomy surgery (OR: 1.60, 95% CI: 1.02 – 2.53). 
Based on the p-values in Table 3, gender, smoking 
habit and radiotherapy affected GC survival more than EC 
survival. In contrast, EC survival was more affected by 
education, marital status, NCD diagnosis status and SES 
comparing to GC. Age at the time of diagnosis, job status, 
and having Esophagectomy surgery showed a similar 
magnitude of effect on both of the cancers.
Discussion 
In this paper, we investigated the possible association 
between the survival of the patients with EC and GC 
and several of the most common prognosis factors. We 
assessed the impact of age at the time of diagnosis, gender, 
education, marital status, job status, smoking habit, NCD 
diagnosis status, Esophagectomy surgery, chemotherapy, 
radiotherapy and socioeconomic status (SES). In the 
current study, being male was a significant indicator of 
prognosis in both univariate and multivariable analysis 
in patients with EC. This finding supports findings from 
Chen et al. where being male was found to significantly 
reduce patients’ survival rates (Eil et al., 2014). In our 
study, high-level socioeconomic status had a positive 
influence on the survival of EC patients in the univariate 
Log-logistic model, which was similarly found in a study 
by Gammon et al., (1997). Our findings also indicated that 
Esophagectomy surgery had a significant effect on the 
survival odds of patients with EC in both univariate and 
multivariable Log-logistic approaches. Previous reports 
have suggested that Esophagectomy surgery increases the 
odds of survival among EC patients (Chen et al., 2013). 
In the current study, married patients in the EC group had 
significantly higher odds of death in the multivariable Log-
logistic model. Previous studies have also demonstrated 
that a patient’s survival is affected by their marital status 
(Ernster et al., 1979; Aizer et al., 2013). The current 
study has found controversy in the results of univariate 
and multivariable approaches regarding radiotherapy. 
Using an intergroup phase III randomized clinical trial, 
Al-saraf et al., (1997) compared the effect of combined 
chemotherapy-radiotherapy versus radiotherapy only in 
patients with locally advanced EC. They found that the 
median survival of patients with combined chemotherapy-
radiotherapy was higher than that of radiotherapy alone. 
Our study has shown that Esophagectomy surgery is an 
essential and outstanding prognostic indicator of GC 
survival in both the univariate and multivariable Log-
logistic model. Improving survival followed by surgery 
was assessed by Hallissey et al., (1994) on a group of 
British GC patients with stomach cancer. They concluded 
that surgery is the standard treatment for GC. However, 
our findings are not consistent with results from the 
prospective randomized controlled trial study by Allum 
et al., (1989) where the effects of surgery with adjuvant 
radiotherapy and chemotherapy in patients with operable 
GC were evaluated. Neither forms of adjuvant therapy 
were associated with the survival of GC patients nor 
surgical treatment remained the principal treatment. 
Parametric and semi-parametric survival models have 
been used widely in fitting survival data. This might be 
due to the fact that the parametric approaches such as 
Log-logistic, Weibull, and Exponential models provide 
accurate estimates with some predetermined assumptions 
(Efron, 1977). The AIC scores in our study revealed that 
the Log-logistic model was the best-fitted model in GC 
and EC datasets. Findings from Ghadimi et al., (2012)’s 
study on patients with GC in the city of Babol, Iran was 
consistent with the findings in the present study. The result 
of our study indicated that in the multivariable log-logistic 
Figure1. Kaplan-Meier Survival Estimate of Patients 
with Esophageal Cancer (Upper) and Gastric Cancer 
(Lower)
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model, the odds ratio of survival among age≥50 in GC is 
lower than EC. Roshanaei et al., (2010) conducted a study 
regarding the survival of patients with GC under surgery 
in which gender pathologic stage, age at diagnosis and 
weight-loss were significantly related to the survival of 
the patients in the multivariable analysis (Roshanaei et al., 
2010). The effect of age at diagnosis has been discussed 
by Zare et al. They demonstrated that the age at diagnosis 
has a significant effect on the survival of patients with GC 
who have undergone surgery (Zare et al., 2014). Moreover, 
Greenstein et al. found that being over 70 reduced the 
chance of survival for patients diagnosed with esophageal 
cancer (Greenstein et al., 2008). 
This study exposed that GC patients are more likely 
to survive after radiotherapy compared to EC patients. 
Moreover, SES has a greater effect on survival time 
among EC patients compared to patients with GC. The 
present study showed that females in both cancers have 
higher odds of survival compared to males. This might 
be related to their riskier lifestyles (Arnal et al., 2015). 
However, males with EC live shorter lives than those with 
GC. In another study in China, Chen et al. revealed that 
the rate of mortality and incidence of EC in males was 
higher than those of patients with GC (Chen et al., 2016). 
Our study showed that married people have higher odds of 
survival. Moreover, those with EC have a higher survival 
time than those with GC. Lagergren et al. assessed the 
impact of marital status, education, and income on the 
risk of esophageal and gastric cancers. They showed that 
patients with long marriages have lower incidence rate 
ratios compared to those with shorter marriages or those 
who were never married, remarried, or divorced. The ratios 
were lower among EC patients in comparison to patients 
with GC (Lagergren et al., 2016). 
There were some limitations on the relatively small 
sample size in our data. The most important limitation 
of the survey was the absence of clinical information 
including the esophageal and gastric cancer type and 
the stage of these cancers. Since this was a retrospective 
cohort study, we did not have access to the information 
on the exposures that patients encountered. 
We conclude that marital status and Esophagectomy 
surgery were potential risk factors for the survival of EC 
patients. Surgical techniques may be a useful method 
to increase the survival rate of patients with esophageal 
cancer. Radiotherapy is an appropriate treatment and may 
decrease death caused by EC. In patients who have already 
had GC surgery, chemotherapy and radiotherapy are 
alternative treatment approaches to increase the survival 
chances of patients with gastric cancer. We founded that 
the Log logistic model could be a proper approach for 
statistical analysis of risk factors in patients with EC and 
GC. 
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